1994
DOI: 10.1099/0022-1317-75-9-2499
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie

Abstract: Transmissible subacute spongiform encephalopathies (TSSE) are neurodegenerative diseases characterized by the presence of a modified, partially proteinase-resistant host protein, PrP s~, which accumulates in the brains of infected individuals. Recently it has been reported that amphotericin B (AmB) treatment of hamsters infected with scrapie strain 263K prolongs the incubation period of the disease, and dissociates in vivo replication of the scrapie agent from PrP s~ accumulation. We report here on data obtain… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
24
0

Year Published

1996
1996
2010
2010

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(30 citation statements)
references
References 21 publications
6
24
0
Order By: Relevance
“…Animals that did not show any clinical signs of scrapie were all negative for the presence of PrPsc. Compared to the 5 ϫ 10 8 to 5 ϫ 10 9 mean LD 50 per gram in intracerebral-infection challenges, these results indicate that intraperitoneal injection of the C506M3 scrapie strain is 10 3 to 10 4 times less efficient than intracerebral inoculation (8,15). These data are very similar to previous findings with other mouse-adapted scrapie strains (14).…”
Section: Resultssupporting
confidence: 82%
See 1 more Smart Citation
“…Animals that did not show any clinical signs of scrapie were all negative for the presence of PrPsc. Compared to the 5 ϫ 10 8 to 5 ϫ 10 9 mean LD 50 per gram in intracerebral-infection challenges, these results indicate that intraperitoneal injection of the C506M3 scrapie strain is 10 3 to 10 4 times less efficient than intracerebral inoculation (8,15). These data are very similar to previous findings with other mouse-adapted scrapie strains (14).…”
Section: Resultssupporting
confidence: 82%
“…The mouse-adapted scrapie strain C506M3 was stabilized and propagated in the C57BL/6 mouse line (17). The inoculum was a brain homogenate at 10% (wt/vol) in 5% glucose solution from a mouse with scrapie at the terminal stage of disease, routinely titrating 5 ϫ 10 8 to 5 ϫ 10 9 50% lethal doses (LD 50 ) per gram in intracerebral-infection challenges (8,15). The mean survival time was around 173 Ϯ 5 (standard deviation [SD]) days after intracerebral infection or 333 Ϯ 7 (SD) days after intraperitoneal challenge (8,17).…”
Section: Methodsmentioning
confidence: 99%
“…While it is hardly practical to consider complete replacement of conventional animals by PrP knockout counterparts, herds of BSEresistant cattle would be useful as a source for products required for pharmaceutical purposes. Moreover, the fact that Prnp °/+ heterozygous mice show prolonged scrapie incubation times argues that an (as yet conjectural) drug leading to moderate reduction of PrP c synthesis or one retarding the conversion of PrP c to PrP sc [72] might substantially mitigate disease progression in incipient cases of human spongiform encephalopathies.…”
Section: Implications and Outlookmentioning
confidence: 99%
“…Among them are polyene antibiotics such as amphotericin B (44) and its more efficient derivative MS-8209 (1-4, 14, 15), polyanions such as dextran sulfate 500 (DS500), heteropolyanions (such as HPA23) or sulfated polyanions (such as SP54) (19,21,23,31,34), and Congo red (CR) (30). Polyene antibiotics and polyanions prolong the survival time of scrapie-infected rodents and transiently reduce brain infectivity and PrPres accumulation (1,4,14,21,44). In addition, sulfated polyanions and CR inhibit PrPres accumulation and infectivity in a model of scrapie-infected mouse neuroblastoma cells (11)(12)(13).…”
mentioning
confidence: 99%